Showing results (111-120 of 952) with videos related to
Sort By:
Pageof 96
Trials|October 11, 2012
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approachStephen Wright, Paul Duncombe, Douglas G AltmanStatistics in Medicine|September 5, 2002
Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomesFrançois Curtin, Diana Elbourne, Douglas G AltmanEuropean Radiology|January 21, 2015
Disadvantages of using the area under the receiver operating characteristic curve to assess imaging tests: a discussion and proposal for an alternative approachSteve Halligan, Douglas G Altman, Susan MallettStatistics in Medicine|October 12, 2005
Dichotomizing continuous predictors in multiple regression: a bad ideaPatrick Royston, Douglas G Altman, Willi SauerbreiILAR Journal|October 23, 2002
Guidelines for the design and statistical analysis of experiments using laboratory animalsMichael F W Festing, Douglas G AltmanMaturitas|March 24, 2012
Reporting clinical research: guidance to encourage accurate and transparent research reportingIveta Simera, Shona Kirtley, Douglas G AltmanStatistics in Medicine|September 5, 2002
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomesFrançois Curtin, Douglas G Altman, Diana ElbournePlos Medicine|May 25, 2016
Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional StudyMatthew J Page, Larissa Shamseer, Douglas G Altman, et al.Plos Medicine|October 19, 2016
Core Outcome Set-STAndards for Reporting: The COS-STAR StatementJamie J Kirkham, Sarah Gorst, Douglas G Altman, et al.F1000Research|August 7, 2018
Who and why do researchers opt to publish in post-publication peer review platforms? - findings from a review and survey of F1000 ResearchJamie Kirkham, David MoherPageof 96